CAS: 1191951-57-1 - 4-Dodecyl-N-1,3,4-thiadiazol-2-ylbenzenesulfonamide
Formula:C20H31N3O2S2
InChI:InChI=1S/C20H31N3O2S2/c1-2-3-4-5-6-7-8-9-10-11-12-18-13-15-19(16-14-18)27(24,25)23-20-22-21-17-26-20/h13-17H,2-12H2,1H3,(H,22,23)
InChI key:InChIKey=BYWWNRBKPCPJMG-UHFFFAOYSA-N
SMILES:O=S(=O)(NC1=NN=CS1)C2=CC=C(C=C2)CCCCCCCCCCCC
- Synonyms:
- 4-Dodecyl-N-1,3,4-thiadiazol-2-ylbenzenesulfonamide
- Benzenesulfonamide, 4-dodecyl-N-1,3,4-thiadiazol-2-yl-
- PHT 427
Benzenesulfonamide, 4-dodecyl-N-1,3,4-thiadiazol-2-yl-
CAS:1191951-57-1
Formula:
C20H31N3O2S2
Purity:
98%
Color and Shape:
Solid
Molecular weight:
409.6090
Ref: IN-DA000IAU
10mg | 120.00 € | ||
25mg | 139.00 € | ||
50mg | 168.00 € | ||
100mg | 283.00 € |
Estimated delivery in United States, on Thursday 12 Dec 2024
PHT-427
CAS:1191951-57-1
PHT-427 (CS-0223) is a dual Akt (Ki: 2.7 μM) and PDPK1 (Ki: 5.2 μM) inhibitor …
Formula:
C20H31N3O2S2
Purity:
100% - 99.77%
Color and Shape:
Solid
Molecular weight:
409.61
Ref: TM-T2420
10mg | 46.00 € | ||
25mg | 86.00 € | ||
50mg | 151.00 € | ||
100mg | 247.00 € | ||
200mg | 424.00 € | ||
1mL*10mM (DMSO) | 51.00 € |
Estimated delivery in United States, on Thursday 19 Dec 2024
PHT-427
Controlled ProductCAS:1191951-57-1
Applications PHT-427 is a pleckstrin homology domain inhibitor to Akt and PKB Kinase (PDPK1). It …
Formula:
C20H31N3O2S2
Color and Shape:
Neat
Molecular weight:
409.61
Ref: TR-P399158
10mg | 125.00 € | ||
25mg | 236.00 € |
Estimated delivery in United States, on Wednesday 22 Jan 2025
PHT-427-d4 (Major)
Controlled ProductCAS:1191951-57-1
Formula:
C20H27D4N3O2S2
Color and Shape:
Neat
Molecular weight:
413.63
Ref: TR-P399157
10mg | 2,184.00 € |
Estimated delivery in United States, on Wednesday 22 Jan 2025
Akt Inhibitor XIV
CAS:1191951-57-1
Akt Inhibitor XIV is a growth factor that regulates cell maturation and protein synthesis. Akt …
Formula:
C20H31N3O2S2
Purity:
Min. 95%
Molecular weight:
409.61 g/mol
Ref: 3D-RXB95157
10mg | 211.00 € | ||
100mg | 839.00 € |
Estimated delivery in United States, on Thursday 23 Jan 2025